Suppr超能文献

A 腺苷受体配体与人源多药转运体 ABCG2 的相互作用。

Interaction of A adenosine receptor ligands with the human multidrug transporter ABCG2.

机构信息

Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute (BA, MM, SL, SVA), USA.

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (DKT, JY, RGC, ZGG, KAJ), National Institutes of Health, Bethesda, MD, 20892, USA.

出版信息

Eur J Med Chem. 2022 Mar 5;231:114103. doi: 10.1016/j.ejmech.2022.114103. Epub 2022 Jan 10.

Abstract

Various adenosine receptor nucleoside-like ligands were found to modulate ATP hydrolysis by the multidrug transporter ABCG2. Both ribose-containing and rigidified (N)-methanocarba nucleosides (C2-, N- and 5'-modified), as well as adenines (C2-, N-, and deaza modified), were included. 57 compounds out of 63 tested either stimulated (50) or inhibited (7) basal ATPase activity. Structure-activity analysis showed a separation of adenosine receptor and ABCG2 activities. The 7-deaza modification had favorable effects in both (N)-methanocarba nucleosides and adenines. Adenine 37c (MRS7608) and (N)-methanocarba 7-deaza-5'-ethyl ester 60 (MRS7343) were found to be potent stimulators of ABCG2 ATPase activity with EC values of 13.2 ± 1.7 and 13.2 ± 2.2 nM, respectively. Both had affinity in the micromolar range for A adenosine receptor and lacked the 5'-amide agonist-enabling group (37c was reported as a weak A antagonist, K 6.82 μM). Compound 60 significantly inhibited ABCG2 substrate transport (IC 0.44 μM). Docking simulations predicted the interaction of 60 with 21 residues in the drug-binding pocket of ABCG2.

摘要

多种腺苷受体核苷类似配体被发现可调节多药转运体 ABCG2 对 ATP 的水解。包含核糖和刚性(N)-甲撑卡巴核苷(C2-、N-和 5'-修饰)以及腺嘌呤(C2-、N-和去氮修饰)。在所测试的 63 种化合物中有 57 种要么刺激(50 种)要么抑制(7 种)基础 ATPase 活性。结构活性分析表明,腺苷受体和 ABCG2 活性可以分开。7-脱氮修饰对(N)-甲撑卡巴核苷和腺嘌呤均有有利影响。腺嘌呤 37c(MRS7608)和(N)-甲撑卡巴 7-脱氮-5'-乙基酯 60(MRS7343)被发现是 ABCG2 ATPase 活性的有效刺激剂,EC 值分别为 13.2±1.7 和 13.2±2.2 nM。两者对 A 腺苷受体均具有亲和力,处于微摩尔范围内,并且缺乏 5'-酰胺激动剂使能基团(37c 被报道为弱 A 拮抗剂,K 6.82 μM)。化合物 60 显著抑制 ABCG2 底物转运(IC 0.44 μM)。对接模拟预测了 60 与 ABCG2 药物结合口袋中的 21 个残基的相互作用。

相似文献

1
Interaction of A adenosine receptor ligands with the human multidrug transporter ABCG2.
Eur J Med Chem. 2022 Mar 5;231:114103. doi: 10.1016/j.ejmech.2022.114103. Epub 2022 Jan 10.
3
Evidence for the Interaction of A Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).
Mol Pharmacol. 2019 Aug;96(2):180-192. doi: 10.1124/mol.118.115295. Epub 2019 May 24.
7
Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
J Pharmacol Exp Ther. 2016 Apr;357(1):24-35. doi: 10.1124/jpet.115.229666. Epub 2016 Jan 26.
10
Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.
Bioorg Med Chem. 2008 Sep 15;16(18):8546-56. doi: 10.1016/j.bmc.2008.08.007. Epub 2008 Aug 7.

引用本文的文献

1
Adenosine A receptor antagonists as anti-tumor treatment in human prostate cancer: an in vitro study.
FEBS Open Bio. 2025 Jul;15(7):1159-1175. doi: 10.1002/2211-5463.70024. Epub 2025 Apr 3.
2
E. B. Hershberg Award: Taming Inflammation by Tuning Purinergic Signaling.
Acc Chem Res. 2025 Mar 18;58(6):958-970. doi: 10.1021/acs.accounts.5c00011. Epub 2025 Mar 5.

本文引用的文献

1
A adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity.
Eur J Med Chem. 2022 Jan 15;228:113983. doi: 10.1016/j.ejmech.2021.113983. Epub 2021 Nov 19.
2
Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.
RSC Med Chem. 2021 Jul 13;12(11):1808-1825. doi: 10.1039/d1md00167a. eCollection 2021 Nov 17.
3
Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2.
J Mol Biol. 2021 Jun 25;433(13):166980. doi: 10.1016/j.jmb.2021.166980. Epub 2021 Apr 8.
5
Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A Receptor Agonists.
ACS Med Chem Lett. 2020 Feb 14;11(10):1935-1941. doi: 10.1021/acsmedchemlett.9b00637. eCollection 2020 Oct 8.
6
Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists.
J Med Chem. 2020 Sep 24;63(18):10412-10432. doi: 10.1021/acs.jmedchem.0c00961. Epub 2020 Sep 11.
7
Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal models.
F1000Res. 2020 Jan 13;9. doi: 10.12688/f1000research.21295.1. eCollection 2020.
8
Evidence for the Interaction of A Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).
Mol Pharmacol. 2019 Aug;96(2):180-192. doi: 10.1124/mol.118.115295. Epub 2019 May 24.
9
Coexpression of ABCB1 and ABCG2 in a Cell Line Model Reveals Both Independent and Additive Transporter Function.
Drug Metab Dispos. 2019 Jul;47(7):715-723. doi: 10.1124/dmd.118.086181. Epub 2019 May 2.
10
Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development.
Front Cell Neurosci. 2019 Mar 28;13:124. doi: 10.3389/fncel.2019.00124. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验